Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04063163 |
|---|---|
| Brief Title: | A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) |
| First Submitted : | August 17, 2019 |
| First Submitted that Met QC Criteria : | August 19, 2019 |
| First Posted : | August 21, 2019 |
| Last Update Submitted that Met QC Criteria : | September 28, 2022 |
| Last Update Posted : | September 30, 2022 |